Loading...
You are here:  Home  >  Health  >  Current News

Roche’s Tecentriq wins FDA approval for treating advanced bladder cancer



(Reuters) - Genentech, a unit of Swiss drugmaker Roche Holding AG, said on Monday it got approval from the U.S. Food and Drug Administration for its already approved immunotherapy drug, Tecentriq, to treat advanced bladder cancer.


Other News

U.S. top court divided over Obamacare contraceptives challenge WASHINGTON (Reuters) - The U.S. Supreme Court on Wednesday appeared to be headed toward a possible 4-4 split over a legal challenge launched by Chri...
India defends right to issue drug ‘compulsory licenses’ MUMBAI (Reuters) - India has defended its right to grant licenses allowing local firms to override patents and make cheaper copies of drugs discover...
AstraZeneca’s lung cancer drug meets main goal in late-stage trial (Reuters) - AstraZeneca Plc said its experimental lung cancer drug Tagrisso met its main goal in a late-stage study.

Found news:

Loading...

You might also like...

Australia’s second largest state edges towards permitting euthanasia

Read More →